Will be at #NeurIPS2023 next week. Happy to meet and chat together about #AIforDrugDiscovery, #GeometricDeepLearning, and #GenerativeModels.

📢After a $10M angel round, we're excited to announce our latest funding round led by Jiangmen Ventures. Funds will accelerate our work in GenAI for protein design w/ applications biomedicine and synthetic biology. 🚀 Stay tuned for more innovations! 🌟 biogeom.com/2024/07/22/bio…

💡Introducing GeoFlow: cutting-edge protein generative model with: 1️⃣SOTA Ab-Ag docking success rates: ≈ AF3, 2x AF2 2️⃣Exceptional design capabilities: GeoFlow generated mAbs w/ novel HCDR3 that have up to 3x binding to the same epitope 🔗Try now at geobiologics-lite.biogeom.com

Excited to deepen our strategic cooperation with Sino Biological Inc.! Combining our protein foundation model GeoFlow with Sino Biological's protein expression and wet lab platform, we aim to set new standards in protein R&D. Learn more at biogeom.com/2024/09/03/bio…

Connect your biologics development to AI with GeoBiologics! 🔬 Harness cutting-edge AI for de novo protein design 🎯 Achieve multi-objective optimization w/ ease 🛠️ Customize solutions to fit your needs ✨ Enjoy an intuitive user experience Try now at geobiologics.biogeom.com

Our GeoBiologics platform boosted the 8G3 antibody’s neutralizing activity by 1000-1500x against JN.1. The study is now out in PNASNews , showing AI’s transformative role in antibody engineering. #AI4Science #drugdiscovery [Study]🔗pnas.org/doi/10.1073/pn…

This week's PrimeView is inspired by the Primer on computational #ProteinDesign out yesterday. Using current knowledge on the physics and chemistry of molecules, machine learning tools can be used to unlock doors to new worlds of proteins. 📖👉:go.nature.com/41zHPaw

🔥(1/5) Introducing GeoFlow V2: A unified atomic diffusion model for protein design -Unifies structure prediction & de novo design w/ versatile constraint support -SOTA results in Ab:Ag folding & epitope-specific Ab design Try it and read our report at prot.design!